BLTE Competitors & Alternatives
Compare Belite Bio Inc ADR with similar stocks in the same industry
Biotechnology
BLTE
Main Stock$148.32
Tradestie Score
60
Market Cap
$2.41B
Analyst Upside
+41.9%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CYTK
Cytokinetics Inc.
|
$81.58
|
$6.68B | - | 60 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$109.36
|
$6.64B | - | 55 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$135.72
|
$6.38B | - | 58 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$25.77
|
$6.03B | - | 45 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$50.60
|
$6.02B | - | 50 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 58 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$235.69
|
$5.92B | - | 51 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$55.34
|
$5.80B | 20.0 | 59 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$341.53
|
$5.20B | 49.0 | 59 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$56.29
|
$4.94B | - | 63 | Compare |
More BLTE Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry